1 Market Overview

1.1 Product Overview and Scope of Coronavirus Vaccine

1.2 Classification of Coronavirus Vaccine by Type

1.2.1 Overview: Global Coronavirus Vaccine Market Size by Type: 2022 Versus 2028

1.2.2 Global Coronavirus Vaccine Revenue Market Share by Type in 2029

1.2.3 Coronavirus Inactivated Vaccine

1.2.4 Live Attenuated Coronavirus Vaccine

1.2.5 Coronavirus Vaccine Based On S Protein

1.3 Global Coronavirus Vaccine Market by Application

1.3.1 Overview: Global Coronavirus Vaccine Market Size by Application: 2023 Versus 2029

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Research Institute

1.3.5 Other

1.4 Global Coronavirus Vaccine Market Size & Forecast

1.5 Market Drivers, Restraints and Trends

1.5.1 Coronavirus Vaccine Market Drivers

1.5.2 Coronavirus Vaccine Market Restraints

1.5.3 Coronavirus Vaccine Trends Analysis

2 Company Profiles

2.1 Іnоvіо Рhаrmасеutісаlѕ

2.1.1 Іnоvіо Рhаrmасеutісаlѕ Details

2.1.2 Іnоvіо Рhаrmасеutісаlѕ Major Business

2.1.3 Іnоvіо Рhаrmасеutісаlѕ Coronavirus Vaccine Product and Solutions

2.1.4 Іnоvіо Рhаrmасеutісаlѕ Recent Developments and Future Plans

2.2 Моdеrnа

2.2.1 Моdеrnа Details

2.2.2 Моdеrnа Major Business

2.2.3 Моdеrnа Coronavirus Vaccine Product and Solutions

2.2.4 Моdеrnа Recent Developments and Future Plans

2.3 Nоvаvах

2.3.1 Nоvаvах Details

2.3.2 Nоvаvах Major Business

2.3.3 Nоvаvах Coronavirus Vaccine Product and Solutions

2.3.4 Nоvаvах Recent Developments and Future Plans

2.4 Рrоtеіn Роtеntіаl

2.4.1 Рrоtеіn Роtеntіаl Details

2.4.2 Рrоtеіn Роtеntіаl Major Business

2.4.3 Рrоtеіn Роtеntіаl Coronavirus Vaccine Product and Solutions

2.4.4 Рrоtеіn Роtеntіаl Recent Developments and Future Plans

2.5 АlрhаVах

2.5.1 АlрhаVах Details

2.5.2 АlрhаVах Major Business

2.5.3 АlрhаVах Coronavirus Vaccine Product and Solutions

2.5.4 АlрhаVах Recent Developments and Future Plans

2.6 Ѕуnаіrgеn РLС

2.6.1 Ѕуnаіrgеn РLС Details

2.6.2 Ѕуnаіrgеn РLС Major Business

2.6.3 Ѕуnаіrgеn РLС Coronavirus Vaccine Product and Solutions

2.6.4 Ѕуnаіrgеn РLС Recent Developments and Future Plans

2.7 NаnоVіrісіdеѕ

2.7.1 NаnоVіrісіdеѕ Details

2.7.2 NаnоVіrісіdеѕ Major Business

2.7.3 NаnоVіrісіdеѕ Coronavirus Vaccine Product and Solutions

2.7.4 NаnоVіrісіdеѕ Recent Developments and Future Plans

2.8 GGеnеСurе

2.8.1 GGеnеСurе Details

2.8.2 GGеnеСurе Major Business

2.8.3 GGеnеСurе Coronavirus Vaccine Product and Solutions

2.8.4 GGеnеСurе Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Coronavirus Vaccine Revenue and Share by Players (2023 & 2029)

3.2 Coronavirus Vaccine Players Head Office, Products and Services Provided

3.3 Coronavirus Vaccine Mergers & Acquisitions

3.4 Coronavirus Vaccine New Entrants and Expansion Plans

4 Global Coronavirus Vaccine Forecast by Region

4.1 Global Coronavirus Vaccine Market Size by Region: 2023 VS 2029

4.2 Global Coronavirus Vaccine Market Size by Region, (2023-2029)

4.3 North America

4.3.1 Key Companies of Coronavirus Vaccine in North America

4.3.2 Current Situation and Forecast of Coronavirus Vaccine in North America

4.3.3 North America Coronavirus Vaccine Market Size and Prospect (2023-2029)

4.4 Europe

4.4.1 Key Companies of Coronavirus Vaccine in Europe

4.4.2 Current Situation and Forecast of Coronavirus Vaccine in Europe

4.4.3 Europe Coronavirus Vaccine Market Size and Prospect (2023-2029)

4.5 Asia-Pacific

4.5.1 Key Companies of Coronavirus Vaccine in Asia-Pacific

4.5.2 Current Situation and Forecast of Coronavirus Vaccine in Asia-Pacific

4.5.3 Asia-Pacific Coronavirus Vaccine Market Size and Prospect (2023-2029)

4.5.4 China

4.5.5 Japan

4.5.6 South Korea

4.6 South America

4.6.1 Key Companies of Coronavirus Vaccine in South America

4.6.2 Current Situation and Forecast of Coronavirus Vaccine in South America

4.6.3 South America Coronavirus Vaccine Market Size and Prospect (2023-2029)

4.7 Middle East & Africa

4.7.1 Key Companies of Coronavirus Vaccine in Middle East & Africa

4.7.2 Current Situation and Forecast of Coronavirus Vaccine in Middle East & Africa

4.7.3 Middle East & Africa Coronavirus Vaccine Market Size and Prospect (2023-2029)

5 Market Size Segment by Type

5.1 Global Coronavirus Vaccine Market Forecast by Type (2023-2029)

5.2 Global Coronavirus Vaccine Market Share Forecast by Type (2023-2029)

6 Market Size Segment by Application

6.1 Global Coronavirus Vaccine Market Forecast by Application (2023-2029)

6.2 Global Coronavirus Vaccine Market Share Forecast by Application (2023-2029)

7 Research Findings and Conclusion

8 Appendix

8.1 Methodology

8.2 Research Process and Data Source

8.3 Disclaimer

List of Tables

Table 1. Global Coronavirus Vaccine Revenue by Type, (USD Million), 2023 VS 2029

Table 2. Global Coronavirus Vaccine Revenue by Application, (USD Million), 2023 VS 2029

Table 3. Іnоvіо Рhаrmасеutісаlѕ Corporate Information, Head Office, and Major Competitors

Table 4. Іnоvіо Рhаrmасеutісаlѕ Major Business

Table 5. Іnоvіо Рhаrmасеutісаlѕ Coronavirus Vaccine Product and Solutions

Table 6. Моdеrnа Corporate Information, Head Office, and Major Competitors

Table 7. Моdеrnа Major Business

Table 8. Моdеrnа Coronavirus Vaccine Product and Solutions

Table 9. Nоvаvах Corporate Information, Head Office, and Major Competitors

Table 10. Nоvаvах Major Business

Table 11. Nоvаvах Coronavirus Vaccine Product and Solutions

Table 12. Рrоtеіn Роtеntіаl Corporate Information, Head Office, and Major Competitors

Table 13. Рrоtеіn Роtеntіаl Major Business

Table 14. Рrоtеіn Роtеntіаl Coronavirus Vaccine Product and Solutions

Table 15. АlрhаVах Corporate Information, Head Office, and Major Competitors

Table 16. АlрhаVах Major Business

Table 17. АlрhаVах Coronavirus Vaccine Product and Solutions

Table 18. Ѕуnаіrgеn РLС Corporate Information, Head Office, and Major Competitors

Table 19. Ѕуnаіrgеn РLС Major Business

Table 20. Ѕуnаіrgеn РLС Coronavirus Vaccine Product and Solutions

Table 21. NаnоVіrісіdеѕ Corporate Information, Head Office, and Major Competitors

Table 22. NаnоVіrісіdеѕ Major Business

Table 23. NаnоVіrісіdеѕ Coronavirus Vaccine Product and Solutions

Table 24. GGеnеСurе Corporate Information, Head Office, and Major Competitors

Table 25. GGеnеСurе Major Business

Table 26. GGеnеСurе Coronavirus Vaccine Product and Solutions

Table 27. Global Coronavirus Vaccine Revenue (USD Million) by Players (2023 & 2029)

Table 28. Global Coronavirus Vaccine Revenue Share by Players (2023 & 2029)

Table 29. Coronavirus Vaccine Players Head Office, Products and Services Provided

Table 30. Coronavirus Vaccine Mergers & Acquisitions in the Past Five Years

Table 31. Coronavirus Vaccine New Entrants and Expansion Plans

Table 32. Global Market Coronavirus Vaccine Revenue (USD Million) Comparison by Region (2023 VS 2029)

Table 33. Global Coronavirus Vaccine Revenue Market Share by Region (2023-2029)

Table 34. Key Companies of Coronavirus Vaccine in North America

Table 35. Current Situation and Forecast of Coronavirus Vaccine in North America

Table 36. Key Companies of Coronavirus Vaccine in Europe

Table 37. Current Situation and Forecast of Coronavirus Vaccine in Europe

Table 38. Key Companies of Coronavirus Vaccine in Asia-Pacific

Table 39. Current Situation and Forecast of Coronavirus Vaccine in Asia-Pacific

Table 40. Key Companies of Coronavirus Vaccine in China

Table 41. Key Companies of Coronavirus Vaccine in Japan

Table 42. Key Companies of Coronavirus Vaccine in South Korea

Table 43. Key Companies of Coronavirus Vaccine in South America

Table 44. Current Situation and Forecast of Coronavirus Vaccine in South America

Table 45. Key Companies of Coronavirus Vaccine in Middle East & Africa

Table 46. Current Situation and Forecast of Coronavirus Vaccine in Middle East & Africa

Table 47. Global Coronavirus Vaccine Revenue Forecast by Type (2023-2029)

Table 48. Global Coronavirus Vaccine Revenue Forecast by Application (2023-2029)

List of Figures

Figure 1. Coronavirus Vaccine Picture

Figure 2. Global Coronavirus Vaccine Revenue Market Share by Type in 2029

Figure 3. Coronavirus Inactivated Vaccine

Figure 4. Live Attenuated Coronavirus Vaccine

Figure 5. Coronavirus Vaccine Based On S Protein

Figure 6. Coronavirus Vaccine Revenue Market Share by Application in 2029

Figure 7. Hospital Picture

Figure 8. Clinic Picture

Figure 9. Research Institute Picture

Figure 10. Other Picture

Figure 11. Global Coronavirus Vaccine Market Size, (USD Million): 2023 VS 2029

Figure 12. Global Coronavirus Vaccine Revenue and Forecast (2023-2029) & (USD Million)

Figure 13. Coronavirus Vaccine Market Drivers

Figure 14. Coronavirus Vaccine Market Restraints

Figure 15. Coronavirus Vaccine Market Trends

Figure 16. Іnоvіо Рhаrmасеutісаlѕ Recent Developments and Future Plans

Figure 17. Моdеrnа Recent Developments and Future Plans

Figure 18. Nоvаvах Recent Developments and Future Plans

Figure 19. Рrоtеіn Роtеntіаl Recent Developments and Future Plans

Figure 20. АlрhаVах Recent Developments and Future Plans

Figure 21. Ѕуnаіrgеn РLС Recent Developments and Future Plans

Figure 22. NаnоVіrісіdеѕ Recent Developments and Future Plans

Figure 23. GGеnеСurе Recent Developments and Future Plans

Figure 24. Global Coronavirus Vaccine Revenue Market Share by Region (2023-2029)

Figure 25. Global Coronavirus Vaccine Revenue Market Share by Region in 2029

Figure 26. North America Coronavirus Vaccine Revenue (USD Million) and Growth Rate (2023-2029)

Figure 27. Europe Coronavirus Vaccine Revenue (USD Million) and Growth Rate (2023-2029)

Figure 28. Asia-Pacific Coronavirus Vaccine Revenue (USD Million) and Growth Rate (2023-2029)

Figure 29. South America Coronavirus Vaccine Revenue (USD Million) and Growth Rate (2023-2029)

Figure 30. Middle East & Africa Coronavirus Vaccine Revenue (USD Million) and Growth Rate (2023-2029)

Figure 31. Global Coronavirus Vaccine Market Share Forecast by Type (2023-2029)

Figure 32. Global Coronavirus Vaccine Market Share Forecast by Application (2023-2029)

Figure 33. Methodology

Figure 34. Research Process and Data Source